EUVIMEDEUVIMED entdecken
Crossref

Metformin as First-Line Therapy in Gestational Diabetes Mellitus (GDM)

Rachna Jain

Diabetes Asia Journal · 24.07.2026 · 3 (2) · 42-44

DOI: 10.62996/daj.84052026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Asia Journal, online erschienen am 24.07.2026. Verfasst von Rachna Jain.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DIPSI (Diagnosis & Management of Gestational Diabetes Mellitus, 2021 — Diabetes in Pregnancy Study Group India, published via FOGSI) does not list metformin as first-line. Insulin is the drug of choice and is recommended for use in pregnancy as it does not cross the placenta (FOGSI/DIPSI, 2021). [1] Metformin has a secondary role: it is useful for obese women or for women who are already on it, but it should not be prescribed for women with GDM if there is significant organ dysfunction, hypertensive disorders of pregnancy, fetal growth restriction, or other high-risk factors (FOGSI/DIPSI, 2021). [1]

Zitieren

APA

Jain, R. (2026). Metformin as First-Line Therapy in Gestational Diabetes Mellitus (GDM). Diabetes Asia Journal, 3(2), 42-44. https://doi.org/10.62996/daj.84052026

Vancouver

Jain R. Metformin as First-Line Therapy in Gestational Diabetes Mellitus (GDM). Diabetes Asia Journal. 2026;3(2):42-44. doi:10.62996/daj.84052026

BibTeX
@article{Jain2026,
  author = {Jain, Rachna},
  title = {Metformin as First-Line Therapy in Gestational Diabetes Mellitus (GDM)},
  journal = {Diabetes Asia Journal},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {42--44},
  doi = {10.62996/daj.84052026}
}
Kostenlos starten →